Showing 2804 results
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
Clinical Trials /
-
-
-
-
Ad hoc release /Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +12% USD) with core operating income1 up +21% (cc, +20% USD)Sales growth driven by continued strong performance from Kisqali (+…
-
Story /
-
Pagination
- ‹ Previous page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- …
- 281
- › Next page